0 XP   0   0   0

Mauna Kea Technologies SAS
Buy, Hold or Sell?

Should you buy, hold or sell Mauna Kea Technologies SAS?

I guess you are interested in Mauna Kea Technologies SAS. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Mauna Kea Technologies SAS

Let's start. I'm going to help you getting a better view of Mauna Kea Technologies SAS. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Mauna Kea Technologies SAS even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Mauna Kea Technologies SAS is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Mauna Kea Technologies SAS. The closing price on 2023-01-27 was €0.476 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Mauna Kea Technologies SAS Daily Candlestick Chart
Mauna Kea Technologies SAS Daily Candlestick Chart
Summary









1. Valuation of Mauna Kea Technologies SAS




Current price per share

€0.48

2. Growth of Mauna Kea Technologies SAS




Is Mauna Kea Technologies SAS growing?

Current yearPrevious yearGrowGrow %
How rich?-$11.2m-$13.1m$1.8m16.9%

How much money is Mauna Kea Technologies SAS making?

Current yearPrevious yearGrowGrow %
Making money-$14.6m-$13.9m-$712.2k-4.9%
Net Profit Margin-174.6%-196.0%--

How much money comes from the company's main activities?

3. Financial Health of Mauna Kea Technologies SAS




Comparing to competitors in the Medical Devices industry




  Industry Rankings (Medical Devices)  


Richest
#378 / 390

Most Revenue
#238 / 390

Most Profit
#303 / 390

Most Efficient
#288 / 390


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

1.1. Profitability of Mauna Kea Technologies SAS.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Mauna Kea Technologies SAS earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • A Net Profit Margin of -174.6% means that €-1.75 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Mauna Kea Technologies SAS:

  • The MRQ is -174.6%. The company is making a huge loss. -2
  • The TTM is -174.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-174.6%TTM-174.6%0.0%
TTM-174.6%YOY-196.0%+21.4%
TTM-174.6%5Y-183.7%+9.1%
5Y-183.7%10Y-156.8%-26.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-174.6%-16.2%-158.4%
TTM-174.6%-15.7%-158.9%
YOY-196.0%-15.1%-180.9%
5Y-183.7%-22.6%-161.1%
10Y-156.8%-24.7%-132.1%
1.1.2. Return on Assets

Shows how efficient Mauna Kea Technologies SAS is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • -54.3% Return on Assets means that Mauna Kea Technologies SAS generated €-0.54 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Mauna Kea Technologies SAS:

  • The MRQ is -54.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -54.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-54.3%TTM-54.3%0.0%
TTM-54.3%YOY-62.1%+7.7%
TTM-54.3%5Y-56.5%+2.2%
5Y-56.5%10Y-49.4%-7.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-54.3%-2.9%-51.4%
TTM-54.3%-2.8%-51.5%
YOY-62.1%-2.2%-59.9%
5Y-56.5%-3.6%-52.9%
10Y-49.4%-3.5%-45.9%
1.1.3. Return on Equity

Shows how efficient Mauna Kea Technologies SAS is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • 0.0% Return on Equity means Mauna Kea Technologies SAS generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Mauna Kea Technologies SAS:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-1,246.8%+1,246.8%
5Y-1,246.8%10Y-655.9%-590.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.2%+3.2%
TTM--3.6%+3.6%
YOY--1.9%+1.9%
5Y-1,246.8%-4.0%-1,242.8%
10Y-655.9%-4.3%-651.6%

1.2. Operating Efficiency of Mauna Kea Technologies SAS.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Mauna Kea Technologies SAS is operating .

  • Measures how much profit Mauna Kea Technologies SAS makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • An Operating Margin of -174.2% means the company generated €-1.74  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Mauna Kea Technologies SAS:

  • The MRQ is -174.2%. The company is operating very inefficient. -2
  • The TTM is -174.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-174.2%TTM-174.2%0.0%
TTM-174.2%YOY-195.2%+21.0%
TTM-174.2%5Y-179.2%+4.9%
5Y-179.2%10Y-154.8%-24.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-174.2%-15.2%-159.0%
TTM-174.2%-14.2%-160.0%
YOY-195.2%-11.0%-184.2%
5Y-179.2%-20.2%-159.0%
10Y-154.8%-22.3%-132.5%
1.2.2. Operating Ratio

Measures how efficient Mauna Kea Technologies SAS is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.48 means that the operating costs are €2.48 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Mauna Kea Technologies SAS:

  • The MRQ is 2.477. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.477. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.477TTM2.4770.000
TTM2.477YOY2.833-0.356
TTM2.4775Y2.658-0.181
5Y2.65810Y2.480+0.178
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4771.418+1.059
TTM2.4771.283+1.194
YOY2.8331.231+1.602
5Y2.6581.325+1.333
10Y2.4801.289+1.191

1.3. Liquidity of Mauna Kea Technologies SAS.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Mauna Kea Technologies SAS is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.54 means the company has €2.54 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Mauna Kea Technologies SAS:

  • The MRQ is 2.544. The company is able to pay all its short-term debts. +1
  • The TTM is 2.544. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.544TTM2.5440.000
TTM2.544YOY2.308+0.235
TTM2.5445Y3.242-0.699
5Y3.24210Y3.886-0.644
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5443.491-0.947
TTM2.5443.832-1.288
YOY2.3083.480-1.172
5Y3.2423.545-0.303
10Y3.8863.273+0.613
1.3.2. Quick Ratio

Measures if Mauna Kea Technologies SAS is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • A Quick Ratio of 1.83 means the company can pay off €1.83 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Mauna Kea Technologies SAS:

  • The MRQ is 1.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.833TTM1.8330.000
TTM1.833YOY1.849-0.016
TTM1.8335Y2.733-0.899
5Y2.73310Y1.948+0.785
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8331.723+0.110
TTM1.8332.035-0.202
YOY1.8491.879-0.030
5Y2.7331.805+0.928
10Y1.9481.775+0.173

1.4. Solvency of Mauna Kea Technologies SAS.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Mauna Kea Technologies SAS assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Mauna Kea Technologies SAS to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.42 means that Mauna Kea Technologies SAS assets are financed with 141.7% credit (debt) and the remaining percentage (100% - 141.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Mauna Kea Technologies SAS:

  • The MRQ is 1.417. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.417. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.417TTM1.4170.000
TTM1.417YOY1.586-0.169
TTM1.4175Y0.997+0.420
5Y0.99710Y0.656+0.341
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4170.339+1.078
TTM1.4170.350+1.067
YOY1.5860.438+1.148
5Y0.9970.467+0.530
10Y0.6560.472+0.184
1.4.2. Debt to Equity Ratio

Measures if Mauna Kea Technologies SAS is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Mauna Kea Technologies SAS:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y18.827-18.827
5Y18.82710Y9.657+9.170
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.462-0.462
TTM-0.462-0.462
YOY-0.581-0.581
5Y18.8270.632+18.195
10Y9.6570.688+8.969

2. Market Valuation of Mauna Kea Technologies SAS

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Mauna Kea Technologies SAS generates.

  • Above 15 is considered overpriced but always compare Mauna Kea Technologies SAS to the Medical Devices industry mean.
  • A PE ratio of -2.55 means the investor is paying €-2.55 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Mauna Kea Technologies SAS:

  • The EOD is -1.585. Company is losing money. -2
  • The MRQ is -2.547. Company is losing money. -2
  • The TTM is -2.547. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-1.585MRQ-2.547+0.962
MRQ-2.547TTM-2.5470.000
TTM-2.547YOY-4.581+2.033
TTM-2.5475Y-7.742+5.194
5Y-7.74210Y-16.412+8.670
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.585-6.306+4.721
MRQ-2.547-6.896+4.349
TTM-2.547-11.813+9.266
YOY-4.581-10.927+6.346
5Y-7.742-9.713+1.971
10Y-16.412-7.673-8.739
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Mauna Kea Technologies SAS.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Mauna Kea Technologies SAS:

  • The MRQ is -2.668. Very Bad. -2
  • The TTM is -2.668. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-2.668TTM-2.6680.000
TTM-2.668YOY-3.940+1.272
TTM-2.6685Y-8.515+5.847
5Y-8.51510Y-24.178+15.663
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6680.013-2.681
TTM-2.6680.046-2.714
YOY-3.9400.027-3.967
5Y-8.5150.068-8.583
10Y-24.1780.047-24.225

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Mauna Kea Technologies SAS is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -3.31 means the investor is paying €-3.31 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Mauna Kea Technologies SAS:

  • The EOD is -2.062. Bad. Book ratio is negative. -2
  • The MRQ is -3.315. Bad. Book ratio is negative. -2
  • The TTM is -3.315. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-2.062MRQ-3.315+1.252
MRQ-3.315TTM-3.3150.000
TTM-3.315YOY-4.851+1.537
TTM-3.3155Y51.398-54.712
5Y51.39810Y32.195+19.203
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.0622.196-4.258
MRQ-3.3152.474-5.789
TTM-3.3153.559-6.874
YOY-4.8514.220-9.071
5Y51.3983.471+47.927
10Y32.1953.042+29.153
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Mauna Kea Technologies SAS compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0400.0400%-0.277+784%-0.096+338%-0.139+443%
Book Value Growth--1.1441.1440%-47.925+4288%-8.954+882%-4.107+459%
Book Value Per Share---0.231-0.2310%-0.271+18%0.012-2059%0.261-188%
Book Value Per Share Growth--1.1491.1490%-47.925+4270%-8.953+879%-4.107+457%
Current Ratio--2.5442.5440%2.308+10%3.242-22%3.886-35%
Debt To Asset Ratio--1.4171.4170%1.586-11%0.997+42%0.656+116%
Debt To Equity Ratio----0%-0%18.827-100%9.657-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.300-0.3000%-0.287-4%-0.290-4%-0.282-6%
Eps Growth--0.9550.9550%1.162-18%0.925+3%0.921+4%
Free Cash Flow Per Share---0.254-0.2540%-0.204-20%-0.246-3%-0.255+1%
Free Cash Flow Per Share Growth--0.7530.7530%1.222-38%0.920-18%0.902-17%
Free Cash Flow To Equity Per Share--0.0730.0730%-0.031+142%0.013+473%-0.091+223%
Free Cash Flow To Equity Per Share Growth--4.3564.3560%-1.002+123%2.399+82%1.700+156%
Gross Profit Margin--1.1641.1640%1.012+15%1.037+12%1.481-21%
Intrinsic Value_10Y_max---1.942--------
Intrinsic Value_10Y_min---1.684--------
Intrinsic Value_1Y_max---0.242--------
Intrinsic Value_1Y_min---0.235--------
Intrinsic Value_3Y_max---0.690--------
Intrinsic Value_3Y_min---0.653--------
Intrinsic Value_5Y_max---1.096--------
Intrinsic Value_5Y_min---1.009--------
Net Profit Margin---1.746-1.7460%-1.960+12%-1.837+5%-1.568-10%
Operating Margin---1.742-1.7420%-1.952+12%-1.792+3%-1.548-11%
Operating Ratio--2.4772.4770%2.833-13%2.658-7%2.4800%
Pb Ratio-2.062+38%-3.315-3.3150%-4.851+46%51.398-106%32.195-110%
Pe Ratio-1.585+38%-2.547-2.5470%-4.581+80%-7.742+204%-16.412+544%
Peg Ratio---2.668-2.6680%-3.940+48%-8.515+219%-24.178+806%
Price Per Share0.476-61%0.7650.7650%1.316-42%2.039-62%4.483-83%
Price To Total Gains Ratio11.763-61%18.90618.9060%-4.752+125%6.769+179%-16.162+185%
Profit Growth--0.9490.9490%1.162-18%0.923+3%0.920+3%
Quick Ratio--1.8331.8330%1.849-1%2.733-33%1.948-6%
Return On Assets---0.543-0.5430%-0.621+14%-0.565+4%-0.494-9%
Return On Equity----0%-0%-12.4680%-6.5590%
Revenue Growth--1.1801.1800%0.878+34%0.986+20%1.073+10%
Total Gains Per Share--0.0400.0400%-0.277+784%-0.096+338%-0.139+443%
Total Gains Per Share Growth--2.1462.1460%0.404+431%1.201+79%1.061+102%
Usd Book Value---11253670.300-11253670.3000%-13153060.700+17%558708.300-2114%12664490.440-189%
Usd Book Value Change Per Share--0.0440.0440%-0.302+784%-0.105+338%-0.151+443%
Usd Book Value Per Share---0.251-0.2510%-0.295+18%0.013-2059%0.285-188%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.327-0.3270%-0.313-4%-0.315-4%-0.307-6%
Usd Free Cash Flow---12384156.100-12384156.1000%-9879226.100-20%-11918674.760-4%-12387423.400+0%
Usd Free Cash Flow Per Share---0.277-0.2770%-0.222-20%-0.267-3%-0.278+1%
Usd Free Cash Flow To Equity Per Share--0.0800.0800%-0.034+142%0.014+473%-0.099+223%
Usd Price Per Share0.518-61%0.8330.8330%1.433-42%2.221-62%4.882-83%
Usd Profit---14642949.500-14642949.5000%-13930678.100-5%-14057667.160-4%-13666898.080-7%
Usd Revenue--8386070.0008386070.0000%7107466.600+18%7646353.280+10%8956867.310-6%
Usd Total Gains Per Share--0.0440.0440%-0.302+784%-0.105+338%-0.151+443%
 EOD+1 -4MRQTTM+0 -0YOY+24 -145Y+23 -1610Y+21 -18

3.2. Fundamental Score

Let's check the fundamental score of Mauna Kea Technologies SAS based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.585
Price to Book Ratio (EOD)Between0-1-2.062
Net Profit Margin (MRQ)Greater than0-1.746
Operating Margin (MRQ)Greater than0-1.742
Quick Ratio (MRQ)Greater than11.833
Current Ratio (MRQ)Greater than12.544
Debt to Asset Ratio (MRQ)Less than11.417
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.543
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Mauna Kea Technologies SAS based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.139
Ma 20Greater thanMa 500.454
Ma 50Greater thanMa 1000.453
Ma 100Greater thanMa 2000.518
OpenGreater thanClose0.457
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Net Invested Capital  23,697-8,66315,034-14,78025413,29013,544-23,876-10,332



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets24,751
Total Liabilities35,084
Total Stockholder Equity-10,332
 As reported
Total Liabilities 35,084
Total Stockholder Equity+ -10,332
Total Assets = 24,751

Assets

Total Assets24,751
Total Current Assets18,667
Long-term Assets18,667
Total Current Assets
Cash And Cash Equivalents 11,866
Short-term Investments 29
Net Receivables 1,532
Other Current Assets 3,759
Total Current Assets  (as reported)18,667
Total Current Assets  (calculated)17,186
+/- 1,481
Long-term Assets
Property Plant Equipment 2,357
Intangible Assets 3,371
Other Assets 1
Long-term Assets  (as reported)6,083
Long-term Assets  (calculated)5,729
+/- 354

Liabilities & Shareholders' Equity

Total Current Liabilities7,339
Long-term Liabilities27,745
Total Stockholder Equity-10,332
Total Current Liabilities
Short-term Debt 1,807
Short Long Term Debt 1,337
Accounts payable 1,667
Other Current Liabilities 3,865
Total Current Liabilities  (as reported)7,339
Total Current Liabilities  (calculated)8,676
+/- 1,337
Long-term Liabilities
Long term Debt Total 26,890
Capital Lease Obligations Min Short Term Debt-694
Other Liabilities 855
Long-term Liabilities  (as reported)27,745
Long-term Liabilities  (calculated)27,051
+/- 694
Total Stockholder Equity
Retained Earnings -13,445
Capital Surplus 111,920
Total Stockholder Equity (as reported)-10,332
Total Stockholder Equity (calculated)98,475
+/- 108,807
Other
Capital Stock1,784
Cash and Short Term Investments 11,895
Common Stock Shares Outstanding 44,771
Liabilities and Stockholders Equity 24,752
Net Debt 16,831
Net Invested Capital -10,332
Net Tangible Assets -11,399
Net Working Capital 11,328
Short Long Term Debt Total 28,697



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
19,359
14,449
11,937
60,300
49,058
39,544
27,538
22,503
19,974
27,747
19,762
23,620
20,609
24,751
24,75120,60923,62019,76227,74719,97422,50327,53839,54449,05860,30011,93714,44919,359
   > Total Current Assets 
0
0
9,199
57,081
45,251
35,235
23,098
18,610
16,349
24,043
15,806
17,778
14,460
18,667
18,66714,46017,77815,80624,04316,34918,61023,09835,23545,25157,0819,19900
       Cash And Cash Equivalents 
12,985
8,064
6,323
51,347
37,638
27,792
15,018
10,620
9,053
17,453
8,623
9,982
8,606
11,866
11,8668,6069,9828,62317,4539,05310,62015,01827,79237,63851,3476,3238,06412,985
       Short-term Investments 
0
0
0
943
211
207
128
65
94
125
64
59
58
29
295859641259465128207211943000
       Net Receivables 
0
2,513
0
3,028
5,348
4,695
5,496
5,133
4,653
4,384
4,330
4,999
2,865
1,532
1,5322,8654,9994,3304,3844,6535,1335,4964,6955,3483,02802,5130
       Inventory 
0
1,420
1,179
1,515
1,936
2,263
1,912
2,644
2,331
1,969
2,456
2,592
2,687
3,013
3,0132,6872,5922,4561,9692,3312,6441,9122,2631,9361,5151,1791,4200
   > Long-term Assets 
0
0
2,738
3,219
3,807
4,309
4,440
3,893
3,625
3,704
3,956
5,842
6,149
6,083
6,0836,1495,8423,9563,7043,6253,8934,4404,3093,8073,2192,73800
       Property Plant Equipment 
458
797
701
563
571
519
794
625
898
1,466
1,985
3,326
2,794
2,357
2,3572,7943,3261,9851,466898625794519571563701797458
       Intangible Assets 
1,346
810
1,975
2,592
1,511
1,632
1,659
1,733
1,629
2,100
1,838
2,343
3,072
3,371
3,3713,0722,3431,8382,1001,6291,7331,6591,6321,5112,5921,9758101,346
       Other Assets 
0
703
0
1,083
1,725
2,158
1,988
1,535
1,098
626
245
1
2,067
1
12,06712456261,0981,5351,9882,1581,7251,08307030
> Total Liabilities 
4,758
4,035
5,075
8,725
8,896
9,385
9,388
8,412
8,817
11,003
11,783
23,368
32,686
35,084
35,08432,68623,36811,78311,0038,8178,4129,3889,3858,8968,7255,0754,0354,758
   > Total Current Liabilities 
3,286
2,372
2,341
5,590
6,053
6,276
6,264
5,984
5,917
4,153
4,904
7,570
6,265
7,339
7,3396,2657,5704,9044,1535,9175,9846,2646,2766,0535,5902,3412,3723,286
       Short-term Debt 
0
0
0
0
211
207
128
65
94
386
600
1,916
722
1,807
1,8077221,91660038694651282072110000
       Short Long Term Debt 
0
0
0
0
0
3,302
3,244
2,901
404
386
600
0
178
1,337
1,33717806003864042,9013,2443,30200000
       Accounts payable 
0
911
0
2,315
2,178
2,439
2,238
2,453
3,131
1,663
2,087
2,275
1,475
1,667
1,6671,4752,2752,0871,6633,1312,4532,2382,4392,1782,31509110
       Other Current Liabilities 
2,689
1,462
2,017
2,297
3,119
3,178
3,388
690
823
2,104
2,110
3,266
3,875
3,865
3,8653,8753,2662,1102,1048236903,3883,1783,1192,2972,0171,4622,689
   > Long-term Liabilities 
0
0
2,734
3,135
2,843
3,109
3,124
2,428
2,900
6,850
6,879
15,798
26,421
27,745
27,74526,42115,7986,8796,8502,9002,4283,1243,1092,8433,1352,73400
       Long term Debt Total 
0
0
0
0
0
0
0
0
2,640
6,567
6,457
14,977
25,416
26,890
26,89025,41614,9776,4576,5672,64000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-211
-207
-128
-65
-94
-386
-600
-1,916
621
-694
-694621-1,916-600-386-94-65-128-207-2110000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
-1
0
1
0
0
0
00010-100000000
       Deferred Long Term Liability 
0
0
0
0
0
2,081
1,883
1,402
936
488
112
841
1,785
2,305
2,3051,7858411124889361,4021,8832,08100000
> Total Stockholder Equity
14,601
10,414
6,862
51,575
40,162
30,159
18,150
14,091
11,157
16,744
7,978
254
-12,077
-10,332
-10,332-12,0772547,97816,74411,15714,09118,15030,15940,16251,5756,86210,41414,601
   Common Stock
14,601
352
6,862
536
542
552
560
647
800
974
1,008
1,223
1,224
1,784
1,7841,2241,2231,0089748006475605525425366,86235214,601
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 0-7,222-6,379-2,679-2,247-1,936-1,748-1,465-1,154-1,1470000
   Capital Surplus 
0
0
0
0
0
0
0
0
72,382
87,973
91,753
98,257
98,286
111,920
111,92098,28698,25791,75387,97372,38200000000
   Treasury Stock0-60-1,370-219-84-72-117-105-138-184-73000
   Other Stockholders Equity 
0
0
0
0
0
-16,240
-26,476
-39,848
-52,209
28,262
22,434
20,682
6,712
1,329
1,3296,71220,68222,43428,262-52,209-39,848-26,476-16,24000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue7,700
Cost of Revenue-1,989
Gross Profit5,7115,711
 
Operating Income (+$)
Gross Profit5,711
Operating Expense-17,082
Operating Income-12,218-11,371
 
Operating Expense (+$)
Research Development3,310
Selling General Administrative3,028
Selling And Marketing Expenses2,207
Operating Expense17,0828,545
 
Net Interest Income (+$)
Interest Income276
Interest Expense-28
Net Interest Income-978248
 
Pretax Income (+$)
Operating Income-12,218
Net Interest Income-978
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-13,445-10,991
EBIT - interestExpense = -13,445
-13,445
-13,417
Interest Expense28
Earnings Before Interest and Taxes (ebit)-13,417-13,417
Earnings Before Interest and Taxes (ebitda)-11,231
 
After tax Income (+$)
Income Before Tax-13,445
Tax Provision--
Net Income From Continuing Ops-13,445-13,445
Net Income-13,445
Net Income Applicable To Common Shares-13,445
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses19,071
Total Other Income/Expenses Net-1,227978
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ALVO.IC
4 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ALVO.IC.

ALVO.IC Daily Candlestick Chart
HURA.TO
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HURA.TO.

HURA.TO Daily Candlestick Chart
IGF.NASDAQ
5 minutes ago

I found you a Golden Cross on the daily chart of IGF.NASDAQ.

IGF.NASDAQ Daily Candlestick Chart
IGBH.NYSE ARC
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IGBH.NYSE ARC.

IGBH.NYSE ARC Daily Candlestick Chart
IFGL.NASDAQ
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IFGL.NASDAQ.

IFGL.NASDAQ Daily Candlestick Chart
IEMG.NYSE ARC
5 minutes ago

I found you a Golden Cross on the daily chart of IEMG.NYSE ARC.

IEMG.NYSE ARC Daily Candlestick Chart
IDRV.NYSE ARC
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IDRV.NYSE ARC.

IDRV.NYSE ARC Daily Candlestick Chart
KESAR.BSE
8 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KESAR.BSE.

KESAR.BSE Daily Candlestick Chart
SGAMY.PINK
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGAMY.PINK.

SGAMY.PINK Daily Candlestick Chart
RUG.V
9 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of RUG.V.

RUG.V Daily Candlestick Chart
FLRK.LSE
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLRK.LSE.

FLRK.LSE Daily Candlestick Chart
3BAB.LSE
10 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BAB.LSE.

3BAB.LSE Daily Candlestick Chart
IWSY.OTCQB
10 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of IWSY.OTCQB.

IWSY.OTCQB Daily Candlestick Chart
HITC.PINK
10 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HITC.PINK.

HITC.PINK Daily Candlestick Chart
ENRT.OTCQB
12 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENRT.OTCQB.

ENRT.OTCQB Daily Candlestick Chart
SCOB.NASDAQ
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCOB.NASDAQ.

SCOB.NASDAQ Daily Candlestick Chart
MDMN.PINK
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MDMN.PINK.

MDMN.PINK Daily Candlestick Chart
TRRE.PINK
13 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of TRRE.PINK.

TRRE.PINK Daily Candlestick Chart
EPWCF.OTCQB
13 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of EPWCF.OTCQB.

EPWCF.OTCQB Daily Candlestick Chart
CSJP.MI
19 minutes ago

I found you a Golden Cross on the daily chart of CSJP.MI.

CSJP.MI Daily Candlestick Chart
EIMU.LSE
23 minutes ago

I found you a Golden Cross on the daily chart of EIMU.LSE.

EIMU.LSE Daily Candlestick Chart
CEM.MI
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEM.MI.

CEM.MI Daily Candlestick Chart
CANCDA.SW
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CANCDA.SW.

CANCDA.SW Daily Candlestick Chart
21W.F
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 21W.F.

21W.F Daily Candlestick Chart
CSPX.LSE
55 minutes ago

I found you a Golden Cross on the daily chart of CSPX.LSE.

CSPX.LSE Daily Candlestick Chart